OUR HISTORY

AstaReal was the first in the world to succeed in commercially culturing Haematococcus pluvialis algae as a source of natural astaxanthin. Since then we have been a pioneer in astaxanthin for over 20 years, and we have continued our R&D to explore its potential in daily health management, prevention and therapy.

Our History

  • 1946

    The Fuji Chemical Group, a parent company of the AstaReal Group, established in Toyama, Japan.

  • 1994

    BioCaroten AB, a bio venture from Uppsala University, Sweden (later acquired by AstaReal)
    succeeded in commercial cultivation of astaxanthin algae for the first time in the world.

  • 1995

    Launched the world’s first natural astaxanthin supplement, Astaxin.

  • 1999

    Began cultivation of astaxanthin algae in Hawaii, the U.S. (Closed in 2011.)

  • 2004

    Established a BtoB sales office in New Jersey, the U.S.

  • 2010

    Obtained the FDA-recognized GRAS (Generally Recognized As Safe)
    status in the U.S. verifying the safety of AstaReal® astaxanthin as a food ingredient.

  • 2014

    Established a second production facility in Washington State, the U.S.

  • 2015

    Established BtoB and retail sales offices in Singapore.

  • 2016

    Established BtoB sales offices in India and Australia.

We supply proprietary astaxanthin
with our know-how and science.
We use cookies to provide the services and features offered on our website, and to improve our user experience. For more information, please see our Privacy Policy. Learn more